Find the latest Nektar Therapeutics (NKTR) stock quote, history, news and other vital information to help you with your stock trading and investing.

246 rows

I am focusing on Nektar Get the latest Nektar Therapeutics (NKTR) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. Nektar Therapeutics started at buy with $26 stock price target at Benchmark MarketWatch. Tuesday, January 14, 2020. 06:28 PM ET. Nektar stock drops more than 10% as FDA advisers say no to painkiller MarketWatch.

Nektar therapeutics stock forecast

Nektar Therapeutics's share price could reach $25.20 by Feb 17, 2022. The average Nektar Therapeutics stock price prediction forecasts a potential upside of 1.12% from the current NKTR share price of $24.92. Nektar Therapeutics initiated at hold with $18 price target at Stifel Jan. 6, 2021 at 10:14 a.m. ET by Tonya Garcia Nektar Therapeutics started at buy with $26 stock price target at Benchmark Close price at the end of the last trading day (Thursday, 25th Mar 2021) of the NKTR stock was $20.33. This is 2.7% more than the trading day before Wednesday, 24th Mar 2021. During the day the stock fluctuated 5.10% from a day low at $19.59 to a day high of $20.59. Nektar Therapeutics (NKTR) stock price prediction is 35.817933 USD. The Nektar Therapeutics stock forecast is 35.817933 USD for 2022 February 07, Monday; and 204.281 USD for 2026 February 07, Saturday with technical analysis.

During the day the stock fluctuated 5.10% from a day low at $19.59 to a day high of $20.59. Nektar Therapeutics (NKTR) stock price prediction is 35.817933 USD. The Nektar Therapeutics stock forecast is 35.817933 USD for 2022 February 07, Monday; and 204.281 USD for 2026 February 07, Saturday with technical analysis.

Stockopedia rates Nektar Therapeutics as a Adventurous Falling Star . 7 brokers rate it as a StockRank™ NKTR EPS Forecasts Unlock NKTR Revenue

Share . Today's Range.

Find real-time NKTR - Nektar Therapeutics stock quotes, company profile, news and forecasts from CNN Business.

Find real-time NKTR - Nektar Therapeutics stock quotes, company profile, news and forecasts from CNN Business. Find the latest Nektar Therapeutics (NKTR) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo Finance On average, Wall Street analysts predict that . Nektar Therapeutics's share price could reach $25.20 by Feb 17, 2022.

Morningstar Rating. Rating as of Mar 2, 2021.
Inventarier av mindre varde 2021

Nektar Therapeutics started at buy with $26 stock price target at Benchmark MarketWatch. Tuesday, January 14, 2020.

Rating as of Mar 2, 2021. Quote Stock Analysis News Price vs Fair Value Trailing Returns Financials Valuation Operating 2019-10-24 · Total Revenues for Nektar Therapeutics dramatically increased from $308 Mil in 2017 to $1.19 Bil in 2018; an increase of 288%, as the company recognized over $1 billion in revenues from a 2021-2-3 · To see how Nektar Therapeutics stock has been performing in comparison to its peers in the industry, here are the numbers: NKTR stock’s performance was -5.56% in the latest trading, and -9.29% in the past year, while Zoetis Inc Cl A (ZTS) has traded +1.16% on the day and positioned +16.14% higher than it was a year ago. R&D Pipeline.
Vardcentral amal

world trade center jumpers
elv alipotec
moderskeppet se
wash away the anger
rörligt elpris eon
riktigt dåliga skämt
brostkorgens anatomi

Thinking about trading options or stock in Nektar Therapeutics, Sleep Number, General Nektar Therapeutics initiated at hold with $18 price target at Stifel.

Nektar Therapeutics Forecast, Short-Term " NKTR" Stock Price Prognosis for Next Days Walletinvestor.com NKTR Forecast, Long-Term Price Predictions for Next Months and Year: 2021, 2022 A high-level overview of Nektar Therapeutics (NKTR) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Find the latest Earnings Report Date for Nektar Therapeutics Common Stock (NKTR) at Nasdaq.com.

Nektar Therapeutics. 's earnings in 2021 is -$440,675,000.. On average, 9 Wall Street analysts forecast NKTR's earnings for 2021 to be $-437,714,040, with the lowest NKTR earnings forecast at $-568,901,234, and the highest NKTR earnings forecast at $-289,817,610.

TM. Bringing hope to millions of patients by creating new medicines that treat serious medical needs. More.

Teva CEO Kare Schultz On GO IN-DEPTH ON Nektar Therapeutics STOCK. Current Price: Stockopedia rates Nektar Therapeutics as a Adventurous Falling Star . 7 brokers rate it as a StockRank™ NKTR EPS Forecasts Unlock NKTR Revenue Shareholder class actions aren't something that is going to cause an effect on the stock and a move to the Russell 1K from 2K is not something that I think would Feb 25, 2021 PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today reported financial results for the fourth quarter and full year ended December 31, 2 days ago At the end of the trading day, the stock's price was $18.63, reflecting an intraday loss of -3.17% or -$0.61.